
Photo from Anand Patel/X
Jun 7, 2024, 13:38
Anand Patel: Imetelstat approved for lower-risk MDS with anemia
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared on X/Twitter:
“Imetelstat approved for lower-risk MDS with anemia in patients treated with or ineligible for ESA!
I remember the excitement from ASCO23 hearing Amer Zeidan presenting IMERGE and then I had the chance to contextualize the data as discussant!”
Source: Anand Patel/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 05:18
Feb 22, 2025, 05:15
Feb 22, 2025, 05:05
Feb 22, 2025, 04:54
Feb 22, 2025, 04:49
Feb 22, 2025, 04:33
Feb 22, 2025, 04:29